THERACLION (EPA:ALTHE) | WebDisclosure

PRESS RELEASE

published on 07/25/2025 at 18:30, 11 months 1 day ago

Informations privilégiées / Communiqué sur comptes, résultats
Theraclion annonce une progression significative au premier semestre 2025, avec une hausse des ventes de consommables, l'expansion en Bulgarie et Espagne, l'accélération de la commercialisation et des avancées dans l'essai clinique FDA

FDA Commercialisation Ventes Progression Theraclion
BRIEF

published on 07/09/2025 at 18:35, 11 months 17 days ago

Review of the first half of 2025 of the Theraclion liquidity contract

Liquidity Contract Half-yearly Report Euronext Growth Theraclion Securities Traded
BRIEF

published on 07/09/2025 at 18:35, 11 months 17 days ago

Bilan du premier semestre 2025 du contrat de liquidité de Theraclion

Contrat De Liquidité Bilan Semestriel Euronext Growth Theraclion Titres Échangés
PRESS RELEASE

published on 07/09/2025 at 18:30, 11 months 17 days ago

Informations privilégiées / Autres communiqués
Présentation du bilan du premier semestre 2025 du contrat de liquidité entre Theraclion et le Crédit Industriel et Commercial, incluant les chiffres clés des transactions. Informations sur Theraclion, société de MedTech développant une alternative non invasive à la chirurgie

Contrat De Liquidité MedTech Bilan SONOVEIN Ultrasons Focalisés
BRIEF

published on 02/20/2025 at 18:35, 1 year 4 months ago

Theraclion sécurise un financement via un emprunt obligataire convertible

Financement Obligations Convertibles Stratégie Commerciale Theraclion R&D Et FDA
BRIEF

published on 02/20/2025 at 18:35, 1 year 4 months ago

Theraclion secures financing via a convertible bond issue

Convertible Bonds Funding Business Strategy Theraclion R&D And FDA
PRESS RELEASE

published on 02/20/2025 at 18:30, 1 year 4 months ago

Informations privilégiées / Opérations de l'émetteur (acquisitions, cessions...)
Theraclion sécurise un financement de 6 millions d'euros auprès de ses actionnaires historiques grâce à un emprunt obligataire convertible. Objectif : poursuite R&D et développement commercial

Actionnaires Financement Emprunt Theraclion Obligataire Convertible
PRESS RELEASE

published on 02/20/2025 at 18:30, 1 year 4 months ago

Inside Information / Operations of the issuer (acquisitions, sales...)
Theraclion secures financing of €6 million through a convertible bond loan with firm commitments from historical shareholders, Furui and Unigestion. CEO Martin Deterre highlights strategic priorities for revenue growth and FDA approval

Financing Strategic Priorities FDA Approval Theraclion Convertible Bond Loan
BRIEF

published on 02/07/2025 at 18:35, 1 year 4 months ago

Publication of Theraclion's adjusted accounts for the first half of 2024

Treasury Theraclion Adjusted Accounts Focused Ultrasound Varicose Veins Walk
BRIEF

published on 02/07/2025 at 18:35, 1 year 4 months ago

Publication des comptes ajustés de Theraclion pour le premier semestre 2024

Trésorerie Theraclion Comptes Ajustés Ultrasons Focalisés Marche Des Varices

Published on 06/27/2026 at 01:40, 24 minutes ago

Polaris Renewable Energy Announces Results of Director Elections at Annual and Special Meeting
Published on 06/27/2026 at 00:00, 2 hours 4 minutes ago

Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010
Published on 06/26/2026 at 23:00, 3 hours 4 minutes ago

Canadian North Resources Inc. Announces Results of 2026 Annual General and Special Shareholders Meeting
Published on 06/26/2026 at 22:50, 3 hours 14 minutes ago

Banyan Gold Files Technical Report for AurMac Project, Yukon, Canada
Published on 06/26/2026 at 22:15, 3 hours 49 minutes ago

Revive Therapeutics Announces Proposed Private Placement

View all ACCESSWIRE

Published on 06/27/2026 at 00:05, 1 hour 58 minutes ago

EAN Congress: Hearing aid use linked to 23% lower dementia risk in people with both epilepsy and hearing loss
Published on 06/27/2026 at 00:04, 1 hour 59 minutes ago

Persistent and Nagarro sign Business Combination Agreement to form the Persistent - Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 2 hours 28 minutes ago

Persistent and Nagarro sign Business Combination Agreement to form the Persistent – Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 2 hours 28 minutes ago

EQS-Adhoc: Nagarro SE: Nagarro signs business combination agreement with Persistent Systems and supports voluntary public takeover offer to all shareholders at EUR 81 per share
Published on 06/26/2026 at 23:27, 2 hours 36 minutes ago

EQS-WpÜG: Takeover Offer / Target company: Nagarro SE; Bidder: Galaxy Germany Holding SE

View all EQS

Published on 06/26/2026 at 17:45, 8 hours 19 minutes ago

Combined General Meeting, June 25, 2026
Published on 06/26/2026 at 17:45, 8 hours 19 minutes ago

Assemblée générale mixte du 25 juin 2026
Published on 06/26/2026 at 17:45, 8 hours 19 minutes ago

Descriptif du programme de rachat d'actions
Published on 06/26/2026 at 14:44, 11 hours 19 minutes ago

Safran information
Published on 06/26/2026 at 14:44, 11 hours 19 minutes ago

Information Safran

View all LES ECHOS COMFI WIRE

News